Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients

Annals of Neurology

Volumn 54, Issue 1, 2003, Pages 119-122

  Alizadeh, Mehdi ^a,b   Babron, Marie Claude ^b,c   Birebent, Brigitte ^a,b   Matsuda, Fumihiko ^d   Quelvennec, Erwann ^a,b   Liblau, Roland ^b,c,d,e   Cournu Rebeix, Isabelle ^b,c,d,e,f   Momigliano Richiardi, Patricia ^g,h   Sequeiros, Jorge ^i,j   Yaouanq, Jacqueline ^{b,c,d,e,f,g,h,i,j,k}   Genin, Emmanuelle ^b,c   Vasilescu, Alexandre ^d   Bougerie, Héloise ^a   Trojano, Maria ^h,i,j,k,l   Silva, Berta Martins ^j,k,l,m   Maciel, Patricia ^l,m,n   Clerget Darpoux, Françoise ^b,c   Clanet, Michel ^b,c,d,e   Edan, Gilles ^{b,c,d,e,f,g,h,i,j,k}   Fontaine, Bertrand ^b,c,d,e,f   Semana, Gilbert ^a,b   more..

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b French Group for MS Genetics   (France)

^c INSERM   (France)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^e CHU PURPAN   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^h Italian Group for MS Genetics   (Italy)

ⁱ UNIVERSITY OF PORTO   (Portugal)

^j Portuguese Group for MS Genetics   (Portugal)

^k PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^l UNIVERSITY OF BARI   (Italy)

^m UNIVERSITY OF PORTO   (Portugal)

ⁿ UNIVERSITY OF MINHO   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR15 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; DISEASE ASSOCIATION; DOT HYBRIDIZATION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; COHORT STUDIES; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IMMUNOBLOTTING; IMMUNOCONJUGATES; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 0037785378     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10617     Document Type: Article

References (20)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-187.
2. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994;54:1-17.
3. Yaouanq J, Semana G, Eichenbaum S, et al. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS. Science 1997;276:664-665.
4. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476.
5. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002;3:611-618.
6. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
7. Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-547.
8. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995;270:985-988.
9. Hurwitz AA, Sullivan TJ, Krummel MF, et al. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol 1997;73:57-62.
10. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
11. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-237.
12. Rasmussen HB, Kelly MA, Francis DA, et al. CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. J Neurol Sci 2001;184:143-147.
13. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-516.
14. Brzustowicz LM, Merette C, Xie X, et al. Molecular and statistical approaches to the detection and correction of errors in genotype databases. Am J Hum Genet 1993;53:1137-1145.
15. Fox CJ, Paterson AD, Mortin-Toth SM, et al. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet 2000;67:67-81.
16. Dyment DA, Steckley JL, Willer CJ, et al. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. J Neuroimmunol 2002;123:193-198.
17. Fukazawa T, Yanagawa T, Kikuchi S, et al. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J Neurol Sci 1999;171:49-55.
18. Harbo HF, Celius EG, Vartdal F, et al. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 1999;53:106-110.
19. Ligers A, Xu C, Saarinen S, et al. The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol 1999;97:182-190.
20. Kantarci OH, Hebrink DD, Achenbach SJ, et al. CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol 2003;134:133-141.